Tests 2001
Tests 2000
Tests 1999


Doping Control Programme









Page 1
Page 2
Declaration of Drug Use Form
  (Please fill out both pages
and return to the FINA Office
by fax: 41 21 310 6610.)


If you do not have Adobe
Acrobat Reader installed on
your computer, please visit 
their web site:







There are never enough of us in this fight for clean sport!

With regard to FINA, we are not sparing our efforts to eradicate this cancer from our sport once and for all.”

 Mustapha Larfaoui, FINA President

It is our pleasure to report FINA’s Doping Control Programme (In & Out-of-Competition) for January-September 2001, and to give a total summary of all tests conducted during this period.  

No positive tests have been reported till the 30th of September 2001.

During the three first quarters 2001, FINA has conducted 1124 tests, In and Unannounced Out-of-competition... more »  

Federation Case

Vasileios Demetis (GRE) appealed to the Greek Athletics Court.

(The Greek Swimming Federation, following its Rules and Regulations as well as the FINA Doping Rules, decided to impose... more
»   )


The FINA Doping Panel decided on 10 February 2001 the following conclusion

Cezar Badita Doping Case

suspension of one (1) year,

shall be imposed on Mr. Cezar Badita, the suspension to start with 10th February 2001.

Also a retroactive sanction involving the 

Cancellation of all results achieved by the swimmer during
the period prior to the date the suspension takes effect
and extending back to six (6) months before 20 May 2000

is imposed. (see complete report » )

Federation Case

The Greek Swimming Federation, following its Rules and Regulations as well as the FINA Doping Rules, decided to impose:

  • A lifetime expulsion to the swimmer Vasileios Demetis after he was sanctioned for doping control second offence (FINA Rule DC 9.1.1. and FINA Rule DC 9.1.5.). The athlete was tested positive for 19-Norandrosterone (36,5n/ml), lidocaine and its metabolite in a doping control carried out on September 5, 2001 with the occasion of the Mediterranean Games in Tunis (TUN).

The athlete had previously tested positive for caffeine in May 2001 and had been sanctioned accordingly.

  • A four (4) years’ suspension to the swimmer Aikaterini Bliamou after she was sanctioned for doping control first offence (FINA Rule DC 9.1.1.). The athlete was tested positive for 19-Norandrosterone (135,9n/ml) in a doping control carried out on September 6, 2001 with the occasion of the Mediterranean Games in Tunis (TUN).



As part of the National Federation Doping Controls 2001 (First semester), swimmers from a total of 9 countries have been tested. It includes a total of 623 tests (In & Out-of-Competition). more »  


In accordance with the FINA Rules DC 12.1, we are pleased to report all results of National Domestic Doping Control programmes for 2000.

As part of the National Federation Doping Controls 2000, swimmers from a total of 21 countries have been tested. It includes a total of 2003 tests (In & Out-of-Competition).  
more »

To all Federations
Please use the following
spreadsheet template (in PDF Format) in order to improve the quality of the National Federation Doping Control Report.


The new list of FINA prohibited substances will take effect on September 1, 2001 and will remain in effect until December 31, 2002.

wishes to clarify its position in relation to some press statements on Erythropoietin (EPO) tests being conducted in connection with the Goodwill Games in Brisbane (AUS)



Appeal to the CAS on July 16, 2001. 



The FINA Doping Panel decided on June 14, 2001 the following conclusion on 
Trent Bray Doping case

A suspension of four (4) years,

Shall be imposed on Mr. Trent Bray, the suspension to start with 19th May 2000, the day when the provisional suspension, decided by the FINA Executive was effective.

"Suspension" shall mean that the swimmer shall not participate in any activities of FINA or any of its Member Federations, in any discipline, including acting as competitor, delegate, coach, leader, physician or other representative of FINA or a Member Federation (FINA Rule DC 9.11).  Also according to FINA Rule DC 9.1.1 a retroactive sanction involving the

cancellation of all results achieved by the swimmer during
 the period prior to the date the suspension
 takes effect and
extending back to six (6) months before 22 November 1999

is imposed


FINA received on January 13, 2000 a report from Australian Sport Drug Testing Laboratory (ASDTL) regarding a positive A-test for Nandrolone on a swimmer from New Zealand. The certificate of the analysis of the sample was issued on January 7, 2000. The Doping control had taken place unannounced out-of-competition in New Zealand, on November 22, 1999.

After having requested information about this doping infraction from Swimming New Zealand, FINA received a short history of the matter dated April 4, 2000. Therein, it could be seen that Trent Bray, as is his right under the New Zealand Drug Agency Act, had filed an appeal against the finding by the New Zealand Sport Drug Agency (NZSDA) of a doping infraction. The appeal was heard by a District Court Judge, who on two grounds out of twenty quashed the NZSDA determination, which left nothing to hear for the Swimming New Zealand Disciplinary Tribunal.

NZSDA has appealed this decision to the High Court of Appeal, which has not yet heard the case.

The FINA DCRB has reviewed the decision by the Judge and found that none of the two grounds on which the Judge quashed the determination had any effect on the final result of the analysis of the sample from Trent Bray.

The Executive has in determining whether or not to provisionally suspend Trent Bray considered the likelihood that he will be found to have violated FINA Doping Control Rules and the unfairness of allowing him to compete pending a final decision in the case.



Trent Bray shall, in accordance with FINA Rule DC 9.6, be provisionally suspended without a hearing from May 19, 2000, until a determination by a competent authority or the FINA Doping Panel has been issued. 


On June 14, 2001 the FINA Doping Panel took a decision with respect to Trent Bray doping case.  Click here to see such FINA Doping Panel Decision. 


As part of their campaign against the use of performance enhancing drugs in swimming FINA invited GH-2000 to send a team out to Hong Kong to the World Short course Swimming Championships in April 1999. GH-2000 offered to provide confidential post-event blood testing to detect the use of GH on swimmers on a voluntary basis. The information gathered was not to be used as evidence of a doping offence but to be used by FINA to see if there was any evidence to suggest that levels of markers of GH in blood different in any way from those of other international athletes, and in particular to assess whether there was any indication of doping amongst any of the swimmers.  Report and results.


Shortly after the end of the FINA Swimming World Cup competition in Berlin (GER) 5-6 February 2000 FINA received information about an incident in the doping control station at the swimming complex.

After having been approached by the Australian Swimming Inc. and United States Swimming, the FINA Executive, on February 8th , decided to request written reports from those present in the doping control station.

Written reports have been provided FINA by the following persons:

February 9th  Dr. Eide Luebs, FINA Medical Delegate
February 16th  Chief Thomas, TSC Member, FINA Delegate
February 17th  Ian Thorpe (AUS) swimmer
February 21st  Lenny Krayzelburg (USA) swimmer, John Skinner (USA) coach
February 23rd  Don Talbot (AUS) coach

Faxletters in this matter have also been received from Terry Gathercole, President, Australian Swimming, Inc, Vena Murray, Executive Director, Australian Swimming Inc., and Chuck Wielgus, Executive Director, United States Swimming, Inc.

The FINA Executive has considered the reports from those persons directly involved in what happened in the doping control station in Berlin. The following observations have been made.

1. No violation of the FINA Doping Control Rules valid from 1 June 1999 has taken place at the doping control neither by the FINA Medical Delegate nor by anybody else.

2. The following remarks made in the reports requested special comments:

a) Although FINA Rule DC 6.4.5 requests that “the competitor must show identification at the doping control station” personal recognition of the competitor by the staff should be acceptable.
b) The use of a German Swimming Federation Doping Control form containing all necessary information does not invalidate the doping control.
c) There is no requirement in FINA Rule DC 8.1.6 that the competitors shall place the A- and B- containers in a transport container.
d) The FINA Rule DC 6.2 requests that “any swimmer establishing or breaking a World Record shall submit to doping control following the race”. It is thus the responsibility of the swimmer to do so.
e) The use of Versapak kits has been approved by FINA.

3. The FINA Executive decided that no action needs to be taken in the matter.


Without correct knowledge about the FINA DC Rules, competitors and coaches should not interfere in the procedures at the doping control station. Medical Delegates appointed by FINA are responsible for the procedures and their decisions and actions must be respected in order not to create any doubt regarding the correctness of doping control at FINA Events. Remarks, if any, shall be directed to FINA without involvement of any third person.

Lausanne, March 1, 2000

The IOC Medical Commission has distributed the following explanatory note which modifies the reporting levels for Salbutamol and Ephedrines: 


Salbutamol is classified as both a stimulant and an anabolic agent.

The intent of unannounced out-of-competition testing is to detect anabolic agents. The revised rules on salbutamol consider it as anabolic agent when its concentration is higher than 500 nanograms/millilitre and confirmed by enantiomeric analysis.

However, pending the acceptance of the enantiomeric analysis by a peer-reviewed journal, only concentrations higher than 1000 nanograms/millilitre will be considered a positive as an anabolic agent until further notice. Samples that contain less than this amount are not to be reported to the authorities for unannounced out-of-competition testing.

In-competition testing is designed to detect the use of salbutamol either as an anabolic agent or as a stimulant. Whether or not the administration of salbutamol is declared is an important issue for in-competition testing.

As always, it is the task of the authorities to interpret the laboratory finding. In order not to overload authorities with the need to confirm medical notifications of non-recent inhaled use, laboratories do not need to report concentrations lower than 100 nanograms/millilitre.

All concentrations above correspond to free (non conjugated) salbutamol.


The pharmacology and urinary pharmacokinetics of the ephedrines were reviewed. The consensus was that the revised cutt-offs would detect all cases of doping where the ephedrines were ingested on the day of competition.

17 January 2000, Lausanne (SUI)

The FINA Doping Control Review Board had its 2nd Meeting on January 17 in Lausanne (SUI), with Dr. Andrew Pipe chairing the meeting. Attending the Meeting were: Mr. Gunnar Werner (FINA Honorary Secretary), Mr. Cornel Marculescu (FINA Executive Director), Prof. J. Malcolm Cameron (FINA Medical Committee Honorary Secretary), Dr. Brian Corrigan (AUS), Prof. Winton Arthur Hawksworth (RSA), Willem L. Mosterd M.D., Ph.D. (NED), Prof. Wu Moutian (CHN), Prof. Jordi Segura (ESP). Only Dr. Bowers was absent.
Some of the main issues discussed in the Meeting were the Review of Application for Exemptions and Review and the protocol for doping tests during Olympic Games and World Championships. The subject of blood testing was also mentioned: Dr. Mosterd expressed an opinion that blood collection is acceptable more in a moral way and it is faster, whilst Dr. Segura said that he did not foresee blood testing replacing urine analysis in the near future. Dr. Pipe stated that there are no reliable tests yet developed and that for the moment this remains a political issue.
It was agreed that the next meeting of the DCRB would be held on November 3, 2000, also in Lausanne (SUI).

1-3 December 1999, Shanghai (CHN)

The FINA delegation was formed by:
Mr. Ross E. Wales, FINA Vice President, Head of Delegation
Mr. Roger Smith, FINA Vice President
Mr. Sam Ramsamy, FINA Bureau Member, FINA Spokesperson
Mr. Pipat Paniangvait, FINA Bureau Member
Mr. Cornel Marculescu, FINA Executive Director

The following is a summary of the FINA Delegation meetings with representatives of the Chinese Swimming Association led by Vice President, Mr. Shi Tianshu.

The delegation also met with representatives of the Shanghai Swimming Association, athletes and coaches and visited the various swimming centres in the city of Shanghai.

Shanghai, China - 1-3 December 1999. FINA concluded their follow-up visit to China today where they received reports on doping control instituted by the Chinese Swimming Association. Previously, the FINA delegation visited China in 1995 and then again in 1998.

The delegation was pleased to learn that most of the recommendations that were jointly agreed upon at the February 1998 meeting had been implemented. Also, the delegation was very satisfied to hear that the Chinese Swimming Association, in conjunction with Chinese Olympic Committee, has instituted blood sampling of swimmers as a pilot project.

Moreover, the FINA delegation learned of more positive actions taken by the Chinese Swimming Association:

1. that the Chinese Swimming Association has strengthened its publicity policy on anti-doping and has expanded its education programme.

2. that there has been a marked increase in the number of unannounced out-of-competition tests. For 1999, 646 tests have already been conducted, 217 in-competition and 429 unannounced out-of-competition. In 1998 4 tests were returned positive and the appropriate sanctions were imposed on the guilty swimmers.

3. that the regulations pertaining to the allotment of cash awards were revised so that only 20% of the money is paid to the swimmers and the coaches and the remainder is only paid four years later, provided that the swimmer does not return a positive drug test.

4. that the Chinese Swimming Association now engages in international exchanges so that the previous suspicions and perceptions are corrected and clarified.

However, there was concern that certain aspects of the initial agreement had either not been fulfilled completely or that their implementation  had not been reported to FINA. The following was pointed out to the Chinese Swimming Association:

1. The issue surrounding  the Chinese Swimming Association's initial proposal to impose more severe sanctions for doping offences than imposed by FINA has been partially diluted. Because the FINA delegation understands the legal and social debate arising out of such severe sanctions, such an amendment should have been adopted in consultation with FINA.

2. There is a lack of fluidity in the communication process between the Chinese Swimming Association and FINA. FINA need to be informed in a timely manner about actions taken by the Chinese Swimming Association. Poor communication has resulted in delays in locating swimmers to conduct the unannounced out-of-competition doping tests.

The FINA delegation understands and accepts that doping in sport is a worldwide problem and not only specific to China.

Therefore, FINA and the Chinese Swimming Association have agreed, as part of the on-going campaign against doping in sport generally and doping in swimming specifically that:

1. the Chinese Swimming Association improve their registration system so that the national and provincial systems are integrated.

2. an official should be appointed solely to deal with doping matters; to connect swimmers with anti-doping education resources and to disseminate the appropriate publicity material to swimmers and coaches.

3. the anti-doping education programme will be extended to all swimmers on the national and provincial levels. 

4. The communication with FINA will be prompt to avoid delays in the execution of decisions and in obtaining the relevant information to clarify positions and perceptions.

5. All actions taken to intensify doping control and strengthen the anti-doping education programmes must be communicated to FINA as soon as possible. These must also be communicated to the media so that the previous negative perceptions of Chinese Swimming Association can be corrected. 

Since February 1998 there have been six positive results returned on the Chinese swimmers. This indicates that the campaign against doping needs to be strengthened. Both parties are committed to pursue anti-doping matters until the issue is brought to a positive and favorable conclusion.

  Competitions   |   Results     |   Calendar  |   Biographies   |   Records  |  Rankings
Press Releases   |     Publications    |   Olympic News   |   Doping News
  Directory   |   Constitution   | Development Programme  | Officials Lists Email

©1996-2001 FINA. All Rights reserved.